Cargando…
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?
Poorly differentiated gastroenteropancreatic neuroendocrine carcinomas are aggressive neoplasms of challenging clinical management. A small proportion of patients with early-stage disease may achieve long-term survival, but the majority of patients present with rapidly lethal metastatic disease. Cur...
Autores principales: | Garcia-Carbonero, Rocio, Anton-Pascual, Beatriz, Modrego, Andrea, del Carmen Riesco-Martinez, Maria, Lens-Pardo, Alberto, Carretero-Puche, Carlos, Rubio-Cuesta, Beatriz, Soldevilla, Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335166/ https://www.ncbi.nlm.nih.gov/pubmed/36879384 http://dx.doi.org/10.1210/endrev/bnad006 |
Ejemplares similares
-
Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance
por: Soldevilla, Beatriz, et al.
Publicado: (2021) -
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms
por: Soldevilla, Beatriz, et al.
Publicado: (2023) -
Targeted Cancer Therapy: What’s New in the Field of Neuroendocrine Neoplasms?
por: La Salvia, Anna, et al.
Publicado: (2021) -
Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review
por: Grande, Enrique, et al.
Publicado: (2019) -
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)
por: Castillón, Jaume Capdevila, et al.
Publicado: (2023)